This med, crizotinib, is all about treating this kind of NSCLC where ALK or ROS1 are the main deal. It works by keeping these kinase proteins (ALK, ROS1, MET) in check – the ones responsible for making cancer grow and spread. It comes in two strengths, a 200-milligram and a 250-milligram capsule.
You’re supposed to take the 250-mg one twice a day, by the way, and you can do it with or without eating. The capsules come in bottles with 60 in each.
